STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] KAMADA LTD Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Kamada Ltd. furnished a Form 6-K that includes a press release reporting strong third-quarter and nine‑month 2025 results, highlighting over 30% year‑over‑year profitability growth. The filing also provides a November 2025 company presentation and unaudited consolidated financial statements as of September 30, 2025. This 6‑K is incorporated by reference into Kamada’s Form S‑8 registration statements.

Positive
  • None.
Negative
  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the Month of November 2025

 

Commission File Number 001-35948

 

Kamada Ltd.

(Translation of registrant’s name into English)

 

2 Holzman Street
Science Park, P.O. Box 4081
Rehovot 7670402
Israel
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

 

 

 

 

  

This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements, File Nos. 333-192720, 333-207933, 333-215983, 333-222891, 333-233267 and 333-265866.

 

1

 

 

The following exhibits are attached:

 

99.1   Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth
     
99.2   Company’s Presentation – November 2025
     
99.3   Kamada Ltd’s Consolidated Financial Statements as of September 30, 2025 (Unaudited)
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

2

 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 10, 2025 KAMADA LTD.
   
  By: /s/ Nir Livneh
   

Nir Livneh

Vice President General Counsel and
Corporate Secretary

 

3

 

 

EXHIBIT INDEX

 

EXHIBIT NO.   DESCRIPTION
99.1   Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth
     
99.2   Company’s Presentation – November 2025
     
99.3   Kamada Ltd’s Consolidated Financial Statements as of September 30, 2025 (Unaudited)
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

4

 

FAQ

What did Kamada (KMDA) file?

Kamada filed a Form 6‑K furnishing a press release, a company presentation, and unaudited consolidated financial statements.

What performance highlight did Kamada share in the 6-K?

The press release headline notes over 30% year‑over‑year profitability growth for third quarter and nine months 2025.

What financial statements are included for KMDA?

Unaudited consolidated financial statements as of September 30, 2025 are included as an exhibit.

Does this 6-K affect Kamada’s registration statements?

Yes. It is incorporated by reference into Kamada’s Form S‑8 registration statements listed in the filing.

What other materials accompany the 6-K for KMDA?

A November 2025 company presentation and Inline XBRL files are included as exhibits.
Kamada Ltd

NASDAQ:KMDA

KMDA Rankings

KMDA Latest News

KMDA Latest SEC Filings

KMDA Stock Data

382.98M
31.45M
7.2%
49.18%
0.09%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Rehovot